#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Cystic fibrosis respiratory infection suppression Breast cancer Extraskeletal ossification Autoimmune haemolytic anaemia Myasthenia gravis Immunodeficiency Necrotising enterocolitis neonatal Orthostatic hypotension Immune-mediated renal disorder Neuronal ceroid lipofuscinosis Intracranial germ cell tumour Progressive familial intrahepatic cholestasis Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Glioblastoma More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Trials in Disease Glycogen storage disease type V Hepatic angiosarcoma – Life with Disease Gaucher’s disease type I – Diagnostics Lymphangiosarcoma – Life with Disease Rhabdoid tumour Metachromatic leukodystrophy Rett syndrome – Basic Information Acquired haemophilia – Treatment Lennox-Gastaut syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olorofim Bt8009 Mcla-129 GLYCYL-TYROSINE Ro7247669 Cyclophosphamide Tetracosactide Ecoo16 SELTOREXANT ADS-019 Syn2 LY3848575 Sertraline Avb-101 Lutetium (177Lu) Oxodotreotide Degarelix Levocetirizine Dihydrochloride Irbesartan Bemarituzumab Cpft Trifluoroacetate More therapies…

    Learn about Your Condition

    Bacteraemia Small cell lung cancer Viral myocarditis Toxic epidermal necrolysis Torticollis Behcet's syndrome Cardiac failure chronic Rett syndrome Tooth loss Intestinal ischaemia Hepatocellular carcinoma Iron deficiency anaemia Toxic nodular goitre Lung neoplasm malignant Ear discomfort More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study testing visugromab, nivolumab, and lenvatinib for patients with advanced liver cancer that cannot be removed by surgery after previous treatment failed

    Recruiting

    2 1 1
    Investigated Drugs:
    • VISUGROMAB
    • Sodium Chloride
    • Lenvatinib
    France Germany Italy Spain

  • A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

    Recruiting

    3 1
    Investigated Drugs:
    • Empasiprubart
    Austria Bulgaria Czechia Denmark Estonia Finland +9

  • A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Czechia Denmark France Germany Hungary Italy +2

  • Study of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • SKB410
    Austria Belgium France Greece Italy The Netherlands +2

  • Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Enzalutamide
    • Apalutamide
    Sweden

  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    • Malignant melanoma
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    • Durvalumab
    • Ipilimumab
    Hungary
Previous Page
1 … 78 79 80 81 82 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!